BusinessProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis ConferenceBy Nasdaq OMXOct 24, 2017, 11:00 AM UTC
BusinessProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis PatientsBy Nasdaq OMXOct 27, 2016, 11:05 AM UTC
BusinessProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis PatientsBy Nasdaq OMXOct 27, 2016, 11:05 AM UTC
BusinessProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFCBy Nasdaq OMXSep 27, 2016, 11:00 AM UTC
BusinessProteostasis Therapeutics Announces Scientific Presentations on New Data at 30th Annual North American Cystic Fibrosis ConferenceBy Nasdaq OMXSep 22, 2016, 11:30 AM UTC
